~~SECURITIES~~UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, DC D.C. 20549

FORM 8-K

CURRENT ~~REPORT~~REPORTPursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

~~Pursuant~~Date toof ~~Section~~Report ~~13 or 15~~(d)Date of ~~the~~earliest ~~Securities~~event ~~Exchange~~reported): October ~~Act~~15, ~~of 1934~~2013

~~Date~~LIVING ofBREATH ~~Report~~ PROJECT, INC.(~~Date~~Exact name of ~~earliest~~registrant ~~event~~as ~~reported): April~~specified ~~12,~~in ~~2013~~its charter)

LIVING BREATH PROJECT, INC.(formerly known as Dilmax Corp.) (Exact name of registrant as specified in its charter)

Nevada	333-175525	99-0365611
(State or Other Jurisdiction	(Commission File	(I.R.S. Employer
of Incorporation)	Number)	Identification Number)

Nevada	333-175525	99-0365611
(State or other jurisdiction	(Commission	(IRS Employer
of incorporation)	File Number)	Identification No.)

P.O. Box 4250, East Hampton, New York 11937
(Address of principal executive offices, including zip code)

~~2360 Corporate Circle Suite 400 Henderson, Nevada 89074~~800-422-0691(~~Address~~Registrant’s oftelephone ~~principal executive offices~~number, including ~~zip~~ area code)

~~(855)~~Check ~~436~~the appropriate box below if the Form 8-~~2427(Registrant’s~~K ~~telephone~~filing ~~number,~~is ~~including~~intended ~~area~~to ~~code)~~simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Copies to: Peter Campitiello, Esq. Kane Kessler, P.C. 1350 Avenue of the Americas New York, New York 10019 Tel: 212-541-6222 Fax: 212-245-3009

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12~~(b)~~ under the Exchange Act (17 CFR 240.14a -12(b))

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e -4(c))

~~ITEM~~Item 45.0103 ~~CHANGES~~Amendments INto ~~REGISTRANT’S~~Articles ~~CERTIFYING~~of ~~ACCOUNTS~~Incorporation or Bylaws; Change in Fiscal Year.

1 On October 15, 2013, upon authority of the majority shareholder of the Registrant’s common stock, par value $0. ~~Previous~~001 per share, and the sole member of the Board of Directors, the ~~Independent~~Registrant ~~Registered~~filed ~~Public~~an ~~Accounting~~amendment ~~Firm~~to the Registrant’s Articles of Incorporation to change the name of the Registrant to Drug Free Solution Inc.

AItem 9. On01 ~~April~~Financial ~~12,~~Statements ~~2013,~~and ~~the Company dismissed its independent registered public accounting firm, M&K CPAS, PLLC (“M&K”).~~Exhibits

B. The reports of M&K for each of the years ended May 31, 2012 and May 31, 2011 did not contain an adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principles other than going concern.

Exhibit No.	Description of Exhibit
3.1	Certificate of Amendment

C. The decision to change accountants was approved by the Company’s board of directors on April 12, 2013, and on such date PKF O'Connor Davies, a division of O'Connor Davies, LLP (“PKF”) was engaged as the Company’s new independent registered public accountants. During the two most recent years or any subsequent interim period prior to engaging PKF, the Company did not consult PKF regarding either: (i) the application of accounting principles to a specified transaction, completed or proposed, or the type of audit opinion that might be rendered on the Company's financial statements, or (ii) any matter that was either the subject of a disagreement or a reportable event in connection with its report on the Company’s financial statements.SIGNATURES

~~D. During~~ Pursuant ~~the~~to ~~Company's two most recent fiscal years and any subsequent interim period preceding April 12, 2013,~~ the ~~date~~requirements of ~~dismissal of M&K, there were no~~ ~~disagreements~~the ~~with~~Securities ~~M&K~~Exchange onAct ~~any matter~~ of ~~accounting principles or practices~~1934, ~~financial~~ ~~statement disclosure, or auditing scope or procedure which, if not resolved to~~ the ~~satisfaction~~Registrant ofhas ~~M&K,~~duly ~~would have~~ caused itthis ~~to make reference~~report to ~~the~~be ~~matter~~signed inon ~~connection with~~ its ~~reports.~~behalf ~~There~~by ~~were no "reportable events" within~~ the ~~two~~undersigned ~~most~~hereunto ~~recent~~duly ~~years and any subsequent interim period preceding the dismissal of M&K in connection with its report on the Company’s financial statements~~authorized.

E. The Company has made the contents of its Form 8-K available to M&K and requested it to furnish a letter to the Securities and Exchange Commission (“Commission”) as to whether M&K agrees or disagrees with, or wishes to clarify the Company's expression of their views. As of the date of this report, we have not received such letter from M&K. When received, the Company will amend this Current Report to include such letter as Exhibit 16.1.

	LIVING BREATH PROJECT, INC.


Date: October 16, 2013	By:	/s/ Genie, O’Malley
		Name: Genie O’Malley
		Title: Chief Executive Officer

~~2. New~~EXHIBIT ~~Independent Registered Public Accounting Firm.~~INDEX

The Registrant has engaged PKF as its new independent certified public accounting firm to audit the Registrant’s financial statements May 31, 2013. During the two most recent years or any subsequent interim period prior to engaging PKF, the Registrant did not consult such firm regarding either (i) the application of accounting principles to a specific completed or contemplated transaction, or the type of audit opinion that might be rendered on the Registrant’s financial statements or (ii) any matter that was either the subject of a disagreement or event identified in response to (a)(1)(iv) of Item 304 of Regulation S-K, or a reportable event as that term is used in Item 304(a)(1)(v) of Item 304 of Regulation S-K.

Exhibit No.	Description of Exhibit
3.1	Certificate of Amendment

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	LIVING BREATH PROJECT, INC.
Date: April 17, 2013	By:	/s/ Genie O’Malley
		Name: Genie O’Malley
		Title: Chief Executive Officer

Filing Compare · Drug Free Solution, Inc.